Detalhe da pesquisa
1.
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Future Oncol
; 20(6): 297-306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916501
2.
New Immuno-oncology Targets and Resistance Mechanisms.
Curr Treat Options Oncol
; 23(9): 1201-1218, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980521
3.
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Lancet Oncol
; 22(7): 959-969, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118197
4.
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.
Oncologist
; 22(7): 786-796, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28487464
5.
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Lancet Oncol
; 17(7): 984-993, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283860
6.
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Int J Cancer
; 135(8): 1869-83, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599876
7.
HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies.
Cancers (Basel)
; 14(17)2022 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077691
8.
Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC.
JTO Clin Res Rep
; 3(5): 100324, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35592617
9.
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
J Palliat Med
; 25(4): 614-619, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847733
10.
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
Cancer Med
; 11(22): 4104-4111, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349227
11.
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
Adv Radiat Oncol
; 7(2): 100857, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387421
12.
Durable Response of Leptomeningeal Disease With Osimertinib and Pemetrexed in EGFR-Mutated Metastatic NSCLC: A Case Report.
JTO Clin Res Rep
; 2(6): 100177, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590025
13.
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
Lancet Diabetes Endocrinol
; 9(8): 491-501, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118198
14.
Outcomes Among Homeless Patients With Non-Small-Cell Lung Cancer: A County Hospital Experience.
JCO Oncol Pract
; 16(9): e1004-e1014, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525753
15.
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.
Clin Lung Cancer
; 21(6): 545-552.e1, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665165
16.
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Clin Cancer Res
; 26(4): 837-845, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796519
17.
Validity of Natural Language Processing for Ascertainment of EGFR and ALK Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.
JCO Clin Cancer Inform
; 3: 1-15, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31058542
18.
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer.
Lung Cancer
; 128: 74-90, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642457
19.
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers.
Clin Cancer Res
; 25(1): 64-72, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206164
20.
Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
Neuro Oncol
; 19(1): i1-i24, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031389